Cosentyx liver pain?

Can Cosentyx cause liver pain?

Cosentyx (secukinumab) belongs to the class of drugs called interleukin-17A inhibitors. It does not directly affect liver function in most patients. Clinical trials and post-marketing reports show that liver enzyme elevations occur in some users, but actual liver pain is rare. Liver tests are recommended before treatment and during the ersten Monate if risk factors exist.

Why do patients report liver pain while on Cosentyx?

Some patients describe upper-right abdominal discomfort that they associate with the injection schedule. These reports often coincide with concurrent use of methotrexate or NSAIDs, medications known to affect liver function. Independent reports submitted to FAERS suggest that combination therapy rather than Cosentyx alone may contribute to the perceived pain.

How long does liver pain last if it occurs?

No clinical study tracks the duration of patient-reported liver pain specifically under Cosentyx. General observations in immunology clinics show that complaints of upper-right discomfort stop after discontinuation of the drug or of the co-administered medications. When pain persists after 2 weeks off treatment, further evaluation for other causes is needed.

What should patients do if they experience liver pain on Cosentyx?

Stop taking Cosentyx only after consulting a physician. Doctors usually order immediate liver function tests and imaging if pain is persistent or severe. Patients with pre-existing liver disease should inform their prescriber before starting the drug.

When does Cosentyx patent expire?

Cosentyx patents expire in 2026 in the United States and 2025 in Europe. Biosimilar versions are already under development by companies such as Samsung Bioepis and Sandoz.